Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Published:2013-01 Issue:1 Volume:24 Page:20-30
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Soria J.-C.,Mauguen A.,Reck M.,Sandler A.B.,Saijo N.,Johnson D.H.,Burcoveanu D.,Fukuoka M.,Besse B.,Pignon J.-P.

Funder

Hoffmann-La Roche Ltd

Ligue National Contre le Cancer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/1/20/13789377/mds590.pdf

Reference53 articles.

1. Global Cancer Facts & Figures;American Cancer Society,2011

2. Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;D'Addario;Ann Oncol,2010

3. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small cell lung cancer. A meta-analysis;Delbaldo;JAMA,2004

4. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy;Hotta;Cancer,2007

5. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer;Jiang;Lung Cancer,2007

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into treatment-specific prognostic somatic mutations in NSCLC from the AACR NSCLC GENIE BPC cohort analysis;BMC Pulmonary Medicine;2024-07-02

2. FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4;EMBO Molecular Medicine;2024-04-08

3. Advances in monotherapy and combination therapy of S-1 for patients with advanced non-small cell lung cancer: a narrative review;Translational Cancer Research;2024-04

4. Co-encapsulation of fisetin and cisplatin into liposomes: Stability considerations and in vivo efficacy on lung cancer animal model;International Journal of Pharmaceutics;2024-02

5. Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements;International Journal of Clinical Oncology;2024-01-28